12 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 21.0% per year over the past 5 years.
Financial health
Total debt ($29M) exceeds cash ($19M); net debt is $10M.
Total debt has grown faster than revenue (65.9% vs 21.0% per year).
Operating income covered interest expense -12.1× in the latest year.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$4M
-$68M
0.0%
-1425.7%
558.9%
-156.3%
-$57M
$29M
$19M
2024
$4M
-$54M
0.0%
-1350.4%
-182.2%
-65.5%
-$46M
$29M
—
2023
$6M
-$63M
0.0%
-1085.7%
-155.3%
-97.6%
-$73M
$3M
$39M
2022
$2M
-$87M
0.0%
-3580.0%
-117.3%
-79.9%
-$65M
$2M
$78M
2021
—
-$58M
—
—
-64.0%
-55.2%
-$49M
$2M
$95M
2020
—
-$22M
—
—
-101.3%
-79.7%
-$15M
$2M
$24M
2019
—
-$20M
—
—
-183.7%
-120.4%
-$17M
$1M
$7M
2018
$0
-$18M
—
—
143.4%
-742.4%
-$12M
$9M
$2M
2017
$0
-$26M
—
—
-595.6%
-239.4%
-$23M
—
$7M
2016
—
-$16M
—
—
-119.5%
-44.9%
—
—
$32M
2015
—
-$32M
—
—
-113.6%
-87.1%
—
—
$31M
2014
—
-$23M
—
—
-42.0%
-34.8%
—
—
$59M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$1M
-$25M
0.0%
-1105.1%
150.3%
-20.0%
-$12M
$2M
$100M
Mar '26
$2M
-$19M
0.0%
-1163.7%
-330.4%
-33.7%
-$22M
$29M
$32M
Dec '25
-$193000
-$18M
0.0%
8805.7%
145.5%
-40.7%
-$14M
$29M
$19M
Sep '25
$2M
-$20M
0.0%
-1006.0%
-567.5%
-34.8%
-$13M
$28M
—
Jun '25
$1M
-$15M
0.0%
-1004.7%
-482.9%
-27.5%
-$11M
$28M
$27M
Mar '25
$1M
-$15M
0.0%
-979.1%
-96.5%
-23.8%
-$19M
$28M
$38M
Dec '24
$764000
-$14M
0.0%
-1811.5%
-46.8%
-16.8%
-$10M
$29M
—
Sep '24
$1M
-$13M
0.0%
-1166.5%
-31.9%
-20.9%
-$12M
$3M
—
Jun '24
$1M
-$15M
0.0%
-1354.0%
-90.3%
-37.7%
-$10M
$3M
$16M
Mar '24
$1M
-$12M
0.0%
-1204.7%
-39.4%
-23.0%
-$13M
$3M
$26M
Dec '23
$1M
-$11M
0.0%
-818.0%
-27.0%
-17.0%
-$14M
$3M
$39M
Sep '23
$4M
-$12M
0.0%
-336.1%
-23.5%
-15.7%
-$17M
$3M
$53M
Jun '23
$485000
-$23M
0.0%
-4853.6%
-38.9%
-25.9%
-$22M
$3M
$71M
Mar '23
$443000
-$17M
0.0%
-4071.1%
-26.7%
-18.0%
-$20M
$2M
$68M
Dec '22
$879000
-$27M
0.0%
-3225.6%
-37.0%
-25.2%
-$19M
$2M
$78M
Sep '22
$466000
-$24M
0.0%
-5388.4%
-27.9%
-20.6%
-$15M
$2M
$102M
Jun '22
$643000
-$21M
0.0%
-3355.5%
-20.2%
-16.5%
-$15M
$2M
$115M
Mar '22
$500000
-$18M
0.0%
-3606.8%
-14.4%
-12.7%
-$15M
$2M
$130M
Dec '21
—
-$15M
—
—
-16.0%
-13.8%
-$13M
$2M
$95M
Sep '21
—
-$11M
—
—
-10.0%
-9.2%
-$8M
$2M
$107M
Valuation over time
How the market has priced OCGN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 116.2× (Mar '23) to 103.0× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is OCGN growing its revenue and profit?
Over the past 5 years, Ocugen, Inc.'s revenue has grown 21.0% per year. These are computed facts, not advice.
How much debt does OCGN have?
As of FY2025, Ocugen, Inc. reported $29M of total debt against $19M of cash; operating income covered interest expense -12.1×.
What is OCGN's profit margin?
In FY2025, gross margin was —, operating margin -1425.7%, and net margin -1540.9%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.